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The T lymphocyte response to pathogens is shaped by the microenvironment. Environ-
mental sensors inT cells include the nutrient-sensing serine/threonine kinases, adenosine
monophosphate-activated protein kinase and mammalian target of rapamycin complex 1.
Other environmental sensors are transcription factors such as hypoxia-inducible factor-1
and the aryl hydrocarbon receptor.The present review explores the molecular basis for the
impact of environmental signals on the differentiation of conventional T cell receptor αβ T
cells and how the T cell response to immune stimuli can coordinate the T cell response to
environmental cues.
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INTRODUCTION
T lymphocytes respond to immune stimulation by clonally
expanding and differentiating to effector cells that produce the
cytokines, chemokines, and cytolytic molecules that mediate adap-
tive immune responses. This process of T cell differentiation
requires the cells to reprogram metabolism to meet the demands
caused by the increases in macromolecule biosynthesis that accom-
pany T cell activation (1–4). Naïve peripheral T cells are thus
small cells that are metabolically quiescent with low rates of
nutrient uptake and protein synthesis. Immune-activated T cells
up-regulate glucose, amino acid, and iron uptake in a response
that increases cellular energy production to support the biosyn-
thesis of the proteins, DNA, and lipids necessary for cell growth
and clonal expansion. Regulation of nutrient uptake is necessary
for the differentiation of both naïve CD4 and CD8 T cells into
effector and memory sub populations (5–7).
Accordingly, there is the potential for the T cell immune
response to be shaped by the T cell nutrient microenvironment. In
this context, it is increasingly recognized that antigen and cytokine
stimuli coordinate how T cells respond to environmental cues
by controlling the expression of nutrient receptors on the T cell
membrane and by controlling the expression and function of
environmental-sensing transcription factors that control T cell dif-
ferentiation (5, 8–10) (Figure 1). The present review will explore
some recent advances in our understanding of how environmen-
tal signals can impact on the differentiation of conventional T cell
receptor (TCR)αβ T cells and how the T cell response to immune
stimuli can coordinate the T cell response to environmental cues.
Specifically, we will review glucose, oxygen, amino acid, and
microbiome sensors and their impact on T lymphocyte biology.
GLUCOSE SENSORS AND T CELLS
Naïve and memory T cells have very low rates of glucose uptake and
predominantly produce ATP via oxidative phosphorylation. T cell
activation during an adaptive immune response is associated with
a rapid up-regulation of the expression of glucose transporters
on the T cell membrane and a corresponding increase in glucose
uptake. Antigen receptor-activated T cells also change from metab-
olizing glucose primarily through oxidative phosphorylation to
also using the glycolytic pathway (3, 11). T cell immune responses
are initiated in response to TCR antigen receptor triggering by cog-
nate peptide/major histocompatibility complexes on the surface of
antigen-presenting cells. Moreover, the T cell response to antigen
is modulated by multiple adhesion molecules and co-stimulatory
molecules and by multiple pro-inflammatory cytokines. These
antigen receptor and co-stimulatory molecules coordinate the sig-
naling pathways that control the changes in glucose metabolism
that underpin T cell immune responses.
The up-regulation of glucose transporter expression and the
glycolytic program of T cells is initiated by antigen and co-
stimulatory molecules via the transcription factor c-myc (12).
However, the expression of glucose transporters and glycolytic
enzymes by antigen-activated T cells can also be sustained by
inflammatory cytokines such as interleukin 2 (13–15). One key
signaling pathway that sustains glucose metabolism is medi-
ated by the serine kinase mammalian target of rapamycin com-
plex 1 (mTORc1) via regulation of hypoxia-inducible factor-
1 (HIF-1) complexes (12, 14, 16). The mTORc1/HIF pathway
sustains glucose metabolism in IL-2-activated CD8+ T cells by
controlling expression of the glucose transporter Glut1 and by
regulating expression of hexokinase 2, a key enzyme which phos-
phorylates glucose to produce glucose-6-phosphate, an essen-
tial intermediate in most pathways for glucose metabolism. The
mTORc1/HIF pathway also controls expression of rate-limiting
glycolytic enzymes in effector T cells such as phosphofructokinase
1, lactate dehydrogenase, and pyruvate kinase M2 (14).
The switch to glycolysis that accompanies T cell activation
makes effector T cells dependent on relatively high levels of glu-
cose transporter expression and exogenous glucose in order to
sustain their transcriptional program (17, 18). There is not a
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FIGURE 1 | A summary of the key metabolic and environmental
sensors that influenceT lymphocyte biology. mTORc1 is inhibited by
AMPK, which is a key glucose sensor. mTORc1 is also influenced by
intracellular amino acid levels such as leucine and glutamine. Oxygen
tensions are sensed by HIF-1α, which remains under the control of
mTORc1. Bacterial virulence factors and metabolites from dietary
tryptophan are sensed by the AhR. AhR and HIF-1α have the same
dimerizing partner – HIF-1β.
full understanding of how glucose metabolism controls T cell
differentiation. However, one key glucose sensor in T cells is the
adenosine monophosphate-activated protein kinase (AMPKα1)
(19). This kinase is phosphorylated and activated by liver kinase
B1 (LKB1) in response to the increases in cellular AMP:ATP ratios
that occur rapidly when metabolically active T cells are glucose
deprived (8, 20). The expression of AMPKα1 is not essential for
effector T cell proliferation or differentiation but it is necessary
for the survival of activated T cells in vivo following withdrawal of
immune stimulation (8). AMPKα1 null CD8+ T cells also show a
striking defect in their ability to generate memory cells following
pathogen infection. The importance of AMPK for T cells reflects
its ability to enforce quiescence to limit energy demands under
conditions of energy stress. Hence, a key role for AMPKα1 is to
restrain the activity of the mTORc1 (8, 21, 22).
Adenosine monophosphate-activated protein kinase can also
stimulate autophagy (23) and in this respect, autophagy has been
shown recently to be critical for the formation of CD8 T cell mem-
ory (24,25). The loss of key molecules that control T cell autophagy
thus pheno-copies the impact of AMPK deletion on the formation
of memory T cells.
Why is it important that activated T cells switch on glycoly-
sis? The glycolytic pathway is a very inefficient way to produce
ATP from glucose and it would seem more logical to use oxidative
phosphorylation as long as oxygen tensions are sufficient. One
explanation is that glycolytic intermediates are used as precur-
sors for nucleotide, amino acid, phospholipid, and triglyceride
biosynthesis. It is also noteworthy that non-metabolic functions
of glycolytic enzymes have been described (26). For example, it
has been described that the glycolytic enzyme GAPDH controls
effector T cell production of the cytokine interferon gamma by
binding to AU-rich elements within the 3′ UTR of IFN-γ mRNA
and hence controlling the translation of this mRNA (18). One
other factor to consider is that the glycolytic products lactic acid
and succinate can function as “signaling” molecules to control
transcriptional responses in macrophages and could well have
similar functions in T cells (27, 28).
OXYGEN SENSORS AND T CELLS
One important environmental factor for T cells is the local oxygen
(O2) tension. The term hypoxia is used to refer to oxygen tensions
below the physiological norm and it is now recognized that naïve
T lymphocytes recirculate through tissues with quite wide ranges
of oxygen saturation. Oxygen tension is thus relatively low in sec-
ondary lymphoid tissues such as lymph nodes compared with the
arterial bloodstream (5 versus 13%) (29). Other tissues that have
comparative hypoxia in healthy hosts include the intestine and skin
(30, 31). It is also clear that effector T cells have to function under
relatively hypoxic conditions, e.g., at sites of tissue inflammation
and within tumor microenvironments where cellular growth rates
supersede rates of angiogenesis and oxygen supply.
The main oxygen sensor in T cells is the transcription factor
hypoxia-inducible factor alpha (HIF-1α). At atmospheric oxygen
tension (21%), HIF-1α is rapidly degraded. This rapid degradation
occurs because proline residues of HIF-1αbecome hydroxylated by
prolyl hydroxylases after which HIF-1α is ubiquitinated by the von-
Hippel–Lindau (Vhl) E3 ligase complex (32, 33) with the resultant
targeting of HIF-1α for degradation. The hydroxylation of HIF-1α
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requires oxygen as a substrate (34) such that HIF-1α degradation is
inhibited when oxygen tension are low. Stabilized, HIF-1α translo-
cates to the nucleus where it dimerizes with HIF-1β (also named
the aryl hydrocarbon nuclear translocator). The HIF-1α/HIF-1β
heterodimer then binds to hypoxia response elements (HREs) in
the promoters of specific genes (29).
In both CD4+ and CD8+ T cells, HIF complexes accumu-
late in effector T cells even under normoxic conditions if these
cells have high levels of mTORc1 activity (14, 16). This probably
reflects that mTORc1 controls the translation of HIF-1α mRNA.
Nevertheless, expression of HIF-1α in effector T cells can also
be rapidly enhanced further by exposure to hypoxia (14). The
HIF-1 pathway is required to sustain expression of multiple genes
encoding proteins that control glycolysis and pyruvate metabo-
lism in effector T cells. The expression of the glucose transporter
GLUT1 is HIF controlled in T cells but the ability of HIF-1 to
sustain glucose metabolism extends beyond a simple model of
HIF-1 regulation of glucose uptake. HIF-1 null effector cytotoxic
T lymphocytes (CTL) thus cannot sustain expression of multiple
rate-limiting glycolytic enzymes; hexokinase 2, pyruvate kinase
2, phosphofructose kinase, and lactate dehydrogenase. Strikingly,
HIF-1 regulates a quite diverse transcriptional program in CTL
and in particular controls expression of cytolytic effector mol-
ecules such as perforin and granzymes. Indeed, when CTL are
switched from normoxic (21%) to hypoxic (1%) oxygen, they sub-
stantially increase expression of HIF-1α and perforin (14). These
results explain observations that CTL cultured under hypoxic
conditions display increased cytotoxic function (Figure 2) (35).
It is also of note that HIF-1-regulated genes in CTL encode
chemokine receptors and adhesion molecules. For example, HIF
activity regulates the expression of the chemokine receptor CCR7
and the cell adhesion molecule CD62L (L-selectin). These mol-
ecules are expressed at high levels in naïve and memory T cells
and are essential for lymphocyte transmigration from the blood
into secondary lymphoid tissue. In contrast, effector CTL down-
regulate CD62L and CCR7 expression as part of the program that
redirects effector T cell trafficking away from lymphoid tissue
toward sites of inflammation (14). In the absence of HIF tran-
scriptional complexes, effector CTL retain expression of CD62L
and CCR7 and they also retain the migratory properties of
naïve/memory T cells and preferentially home to secondary lym-
phoid tissues (14). There is therefore a dominant requirement
for HIF-1 for the normal programing of effector CD8 T cell
trafficking.
HIF transcriptional complexes, the metabolic sensor of cel-
lular oxygen levels, thus act positively to control expression of
glucose transporters and cytolytic effector molecules but have
a role to repress expression of critical chemokine and adhesion
receptors that regulate T cell trafficking. There are thus funda-
mental mechanisms mediated by HIF that link oxygen sensing
and transcriptional control of CD8 T cell differentiation. There is
moreover evidence that HIF signaling is an important regulator
of effector CD8 T cell function. Hence, T cell-specific deletion of
Vhl, which targets HIF for degradation causes increased pathology
in response to chronic viral infection (36) reflecting that HIF sig-
naling seems to limit the terminal differentiation of CD8 T cells.
FIGURE 2 | A model of the regulation and function of HIF
complexes in cytotoxicT cells. Under normoxic conditions, HIF-1α is
rapidly degraded. This rapid degradation occurs because proline
residues of HIF-1α become hydroxylated by prolyl hydroxylases after
which HIF-1α is ubiquitinated by the von-Hippel–Lindau E3 ligase
complex. In hypoxia, the hydroxylation of HIF-1α does not occur and the
transcription factor is no longer targeted for degradation and HIF-1α
protein can thus accumulate within the cell. In effector CD4 and CD8 T
cells, high levels of mTORC1 activity promote HIF-1α translation
allowing moderate levels of HIF complexes to accumulate even under
normoxic conditions. The different regulatory signals that control
mTORc1 activity in T cells are also shown as are some of the gene
targets whose expression is either promoted (blue arrows) or
repressed (red lines) by HIF-1 complexes.
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There are parallel data that oxygen sensing acts via HIF to control
the differentiation of effector CD4 cells (16). The oxygen tension
in the T cell environment will thus have an impact of the T cell
differentiation program.
REGULATION OF AMINO ACID TRANSPORT IN T
LYMPHOCYTES
T cell activation is known to increase rates of amino acid uptake by
increasing expression of key amino acid transporters. For exam-
ple, immune-activated T cells up-regulate expression of glutamine
transporters; members of the sodium-dependent neutral amino
acid transporter (SNAT) family (5, 7). In the context of gluta-
mine uptake, T cells have an absolute requirement for a large
external supply of glutamine and even modest reductions of exter-
nal glutamine concentrations will negatively impact on T cell
proliferation and differentiation (7). Moreover, triggering of the
TCR induces expression of the glutamine transporter ASCT2 in
T cells and the deletion of ASCT2 suppressed the development
of pro-inflammatory CD4 helper 1 (Th1) and Th17 cells in vivo
in mouse models of autoimmunity highlighting the integration
of T cell responses to antigen with changes in T cell glutamine
metabolism (7).
Exposure to pathogens and triggering of the TCR in CD8+ T
cells also induces a striking increase in expression of the System
L amino acid transporter complex that comprises a heterodimer
of CD98 and the large neutral amino acid transporter (LAT1),
encoded by the SLC7A5 gene (5). The regulated expression of
System L amino acid transporters is particularly important for
T cells as these are responsible for cellular uptake of branched
chain and aromatic amino acids such as leucine, isoleucine, tryp-
tophan, and phenylalanine (37). These amino acids are all used
for de novo protein synthesis. System L transport activity in T cells
requires sustained exposure to antigen/pathogen or inflammatory
cytokines such as interleukin 2 (IL-2) and is an example of how
the T cell response to immune stimuli controls the ability of T cells
to respond their environment (5).
The regulated expression of acid transporters is particularly
important for T cells as these mediate the cellular uptake of the
amino acids required for de novo protein synthesis. T cell activation
is thus associated with large increases in protein synthesis to sup-
port the replication of cellular proteins during cell division and
to support the synthesis of the secreted cytokines, chemokines,
and effector molecules. For example, there is a requirement for
sustained leucine uptake for expression of the metabolic regula-
tor c-myc. Slc7a5-null T cells can thus respond to antigen and
cytokines to increase expression of mRNA encoding c-Myc but
they do not express c-Myc protein. Accordingly, Slc7a5-null T
cells are unable to up-regulate the Myc-controlled “metabolic
machinery” required for T cell differentiation (5). For example,
Slc7a5-null T cells are unable to increase glucose and glutamine
uptake in response to TCR antigen receptor engagement.
One important factor in the context of glutamine metabo-
lism in T cells is that the majority of glutamine taken up by
T cells is not used for de novo protein synthesis. Instead, it is
diverted into metabolic intermediates such as pyruvate and par-
ticularly lactate with a small amount being oxidized to carbon
dioxide through the citric acid cycle. The conversion of glutamine
to lactate occurs via a metabolic process known as glutaminoly-
sis whereby glutamine is metabolized to glutamate which is then
converted into α-ketoglutarate. Glutamine metabolized in this
way is not only a metabolic fuel but provides substrates for T
cells to grow and proliferate (12). For example, α-ketoglutarate
can enter an isocitrate dehydrogenase-1 (IDH1)-dependent path-
way to synthesize acetyl coenzyme A (AcCoA): a key biosyn-
thetic precursor for fatty-acid synthesis and protein acetylation.
Here, it is relevant that AcCoA can be produced from glucose-
derived pyruvate but in any cell that has switched to aerobic
glycolysis, there is the possibility of a stoichiometric conversion
of glucose to lactate which will direct glucose-derived carbon
away from the tricarboxylic acid cycle and fatty-acid synthesis.
Under these conditions, cells may become completely dependent
on IDH1-mediated reductive carboxylation of glutamine-derived
α-ketoglutarate for de novo lipogenesis. Note, α-ketoglutarate
also provides the link between glutamine and the Krebs cycle
and here it has been noted that T cell activation is associated
with increased expression of key enzymes such as involved in
glutamine/α-ketoglutarate metabolism notably glutamate dehy-
drogenase (GDH), glutamic-oxaloacetic transaminase (GOT), and
glutamic-pyruvic transaminase (GPT) (38).
It is also noteworthy that mutations in (IDH1) and IDH2
have been found in acute myeloid leukemias (AMLs). These
mutant IDH enzymes have a gain of function activity to cat-
alyze the NADPH-dependent reduction of α-ketoglutarate to
2-hydroxyglutarate (2HG). This latter metabolite can act as a com-
petitive inhibitor of histone lysine demethylases and hence control
histone demethylation and chromatin structure (39). These obser-
vations reveal a clear link between metabolic processes and the
cellular epigenome and afford another insight as to how metabolic
signaling can impact on cellular transcriptional programs.
MAMMALIAN TARGET OF RAPAMYCIN: AN AMINO ACID
SENSOR IN T CELLS
One of the main reasons that it is critical that T cells tightly regu-
late expression of System L amino acid transporters and glutamine
transporters is because the intracellular supply of leucine and glut-
amine regulates the activity of the serine/threonine kinase complex
mTORc1 (2, 40–42). The leucine-sensing pathway that activates
mTORc1 activity is initiated within lysosomes and involves amino
acid-dependent activation of the guanine nucleotide exchange
activity of the Ragulator complex. This results in the accumulation
of active GTP-bound RagA GTPases, which then recruits mTORc1
to the lysosomal surface where it interacts with the small GTPase
Rheb, a potent stimulator of mTORc1 kinase activity in T cells
(43, 44). The full details of how T cells sense intracellular leucine
are not known but it importance and the importance of mTORc1
for effector T cell differentiation has been well documented (2, 5,
45). The molecular basis for the immunosuppressive actions of
mTORC1 inhibitors such as rapamycin is multifaceted. In CD4 T
cells, rapamycin inhibition of mTORC1 prevents the differentia-
tion of Th1 and Th17 but not Th2 cells. Rapamycin also causes
retention or re-expression of FoxP3 in antigen receptor-activated
CD4 T cells and promotes the production of “regulatory” T lym-
phocytes (2, 45). Inhibition of mTORC1 with rapamycin can also
shape CD8 T cell responses to antigen: rapamycin treatment thus
Frontiers in Immunology | T Cell Biology March 2015 | Volume 6 | Article 99 | 4
Ramsay and Cantrell Environmental sensors in T lymphocytes
prevents effector T cell generation and promotes memory T cell
formation (46).
The molecular basis for the importance of mTORc1 for T cell
function is not fully understood and is not the focus of the present
review. However, as discussed above, one key function for mTORc1
is to control expression of HIF-1 transcription factor complexes
which then regulate expression of a diverse array of genes including
glucose transporters, glycolytic enzymes, adhesion molecules, and
cytolytic effector molecules (14, 16). mTORc1-controlled signal-
ing pathways can also control expression of the sterol regulatory
element-binding proteins (SREBP1 and SREBP2); transcription
factors that are required for the expression of lipogenic enzymes
(47). mTOR has thus been linked to the control of lipid biosyn-
thesis in many cells. The relevance of the SREBP pathway in
T lymphocyte biology was suggested when it was demonstrated
that phospholipid-dependent kinase 1 (PDK1), which controls
mTORc1 activity in CD8 T cells (14), controls the transcription
of SREBP gene targets such as hydroxysteroid (17β) dehydroge-
nase 7, fatty-acid desaturase 2, farnesyl diphosphate synthetase,
and stearoyl-coenzyme A desaturase 1 (13). Moreover, SREBP null
CD8 T cells cannot metabolically reprogram to glycolysis and show
attenuated clonal expansion in response to a pathogen challenge
(48). In this context, there is an increasing awareness that the reg-
ulation of de novo fatty-acid synthesis and fatty-acid catabolism is
important for peripheral T cell differentiation (49–51).
MICROBIOME SENSORS AND T CELLS
All mammals are colonized with diverse commensal microbes
especially at barrier sites such as the skin and the gastrointesti-
nal tract and it is now recognized that these resident bacteria have
a key role in controlling immune cell homeostasis and can modu-
late the function of T cells in adaptive immune responses (52, 53).
Importantly, commensal bacteria constantly trigger responses in
gut epithelial cells via host microbial pattern recognition receptors
particularly Toll-like receptors (TLRs). These signals are essential
under normal non-pathogenic steady-state conditions to main-
tain intestinal epithelial homeostasis (54). Commensal microbes
are also essential for controlling the function of lymphocytes at
barrier sites. For example, germ-free mice have smaller Peyer’s
patches and fewer T and B cells in the intestine than mice with
a normal microbial flora. It has also been shown that the differ-
entiation of effector T cell populations can be influenced by the
gut microflora. For example, segmental filamentous bacteria (SFB)
that adhere tightly to the epithelial layer of the intestine have been
shown to drive the differentiation of mucosal Th17 cells (55–58).
As well, the maintenance of regulatory T lymphocytes in the gut
can be modulated by intestinal bacterial colonization (59).
The molecular mechanisms whereby the bacterial environment
controls T cells are complex and a full analysis is beyond the
scope of the present review. One element is that bacterial recogni-
tion by pattern recognition receptors expressed by epithelial cells,
macrophages, and dendritic cells will govern the production of
cytokines and chemokines that can direct T cell fate (60, 61).
Hence, the nature of the pathogen insult/challenge to the innate
immune system, and the resultant cytokine milieu plays a key role
in regulating peripheral T cell differentiation. One more direct
pathway that interprets the microbial environment for T cells is
mediated by the aryl hydrocarbon receptor (AhR), a transcription
factor that has been extensively studies in the context of cellular
responses to environmental toxins. Ligands for the AhR include
dioxins and in the context of toxin binding the AhR translocates
to the nucleus to form a complex with the AhR nuclear transloca-
tor (ARNT) or HIF-1β. This complex then regulates expression of
members of the cytochrome P450 family such as CYP1A1, which
function as xenobiotic metabolizing monooxygenases (10). In the
context of the influence environmental cues have of lymphocyte
population, it is of interest that both HIF-1α and AhR have the
same dimerizing partner HIF-1β/ARNT. This suggests a potential
for cross talk between the hypoxia-induced factors and the AhR
pathways.
The AhR has an important physiological role in T cell immune
responses and can regulate the differentiation of effector CD4 T
cells that make the pro-inflammatory cytokines IL-17 and IL-22
(62). The AhR also controls the development of innate lymphoid
cells (ILCs) at barrier sites such as the intestinal mucosa and the
skin (63). The direct gene targets for the AhR that explain how
it controls T cell differentiation are not known but could be the
cytokine gene promoters themselves.
The AhR was first studied in the context of environmental
toxins such as dioxins [e.g., d2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) ligands]. However, it is the identity of physiologically
relevant AhR ligands that has captivated the immunological com-
munity. One key discovery was that exposure of tryptophan to
ultraviolet light from solar irradiation (in particular UVB) results
in the production of a potent AhR ligand 6-formylindolo(3,2-
b)carbazole (FICZ) (10). Moreover, AhR null mice have a 90%
reduction of TCRγδ+ skin T cells. (64). In addition, activa-
tion of the AhR dampens the severity of immune-mediated skin
inflammation (65).
It has been proposed that AhR activity in gut lymphocytes
can be regulated by the metabolism of nutritional components
notably tryptophan catabolites produced by diets rich in crucifer-
ous vegetables (66). One product of tryptophan metabolism that
functions as an AhR ligand is kynurenine (67, 68). In this respect,
high levels of kynurenine production by human tumors have been
proposed to suppress antitumor immune responses and hence
promote tumor-cell survival (67). The generation of kynurenine
from tryptophan metabolism occurs via the enzymes indoleamine
2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO).
The production of AhR ligands from tryptophan metabolites
could explain how the diet can shape gut immune responses. The
AhR is thus important for the development and maintenance of
multiple subpopulations of gut lymphocytes. (69). However, one
consideration is that diet alterations might change the bacterial
milieu and indirectly regulate gut lymphocytes by controlling the
diversity of gut commensal bacteria. In this respect, there is an
increasing recognition that the bacterial microbiome can pro-
duce ligands for the AhR notably tryptophan metabolites. The
AhR can thus act as a link between the host immune system
and the commensal microbiota. There is also recent evidence that
AhR is able to sense pathogenic microbes. Bacterial-pigmented
virulence factors, namely phenazines from Pseudomonas aerug-
inosa and the naphthoquinone phthiocol from Mycobacterium
tuberculosis, are thus strong AhR ligands. Importantly, there is
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evidence that AhR null mice are more prone to infections with
these organisms (70).
CONCLUSION
T cell responses to pathogens can be shaped by the localized
microenvironment. T cell differentiation can be regulated by
the bacterial environment because many of the cytokines and
chemokines produced when pattern recognition receptors in cells
of the innate immune system are triggered by bacterial products
and subsequently control the adaptive immune response by acting
on T cells. What is now emerging is that the bacterial environment
can more directly regulate T cell responses. For example, T cells
can be directly regulated by bacterial products that activate the
AhR transcriptional pathway.
One other advance in our understanding of T cell biology is
how the oxygen and nutrient environment can shape T cell differ-
entiation. Moreover, that T cells are not just passive in the way they
interact with their environment. T cells can thus control how they
respond to the environment by restricting expression of high lev-
els of nutrient receptors and environmental-sensing transcription
factors to immune-activated T cells. The value of these insights
is that they inform novel strategies to therapeutically manipulate
T cell immune responses. For example, metformin, a drug that
inhibits the respiratory chain complex I can promote the develop-
ment of memory CD8 T cell-mediated immune responses arguing
that it might be useful tool in vaccine development (71).
Tactics that promote signaling via the oxygen sensor HIF-1α
have also been shown to promote the production of effector CD8
T cells, which could be important for strategies aimed at the clear-
ance of viruses and tumors. In a similar context, strategies that
activate the AhR have been shown to reduce inflammation in
autoimmune-mediated skin conditions. Metabolic diseases such
as obesity and diabetes could also be managed by modulation of
the immune system. Recent discoveries have identified that innate
lymphoid cell 2 subset (ILC2s) dysregulation is a conserved fea-
ture of obesity and manipulation of the IL-33/ILC2 axis may lead
to therapies for this disease (72). The field of immunotherapy is
entering a new era where targeting of pathways that influence
the way T cells sense their environment may yield immune-
modulatory drugs that are as valuable as those that currently target
T cell-specific antigen and cytokine receptor signaling molecules.
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